Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Strong Sell

Simple Moving Average

Buy

Exponential Moving Average

Neutral

Relative Strength Index

Neutral

Standard Deviation

Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Sell

C

Codexis, Inc. (CDXS)

Industrial Organic Chemicals

https://www.codexis.com

Codexis Inc is involved in the business of providing enzyme optimization services, commercialization of proteins, and developing biocatalyst products. The firm's products and services include Screening and Evolution services, Enzymes, Screening Kits. It also develops protein engineering and biocatalyst platforms such as Codeevolver, Ketoreductases, Transminases, Imine reductases, etc. The company operates in two business segments namely Performance Enzymes and Novel Biotherapeutics. It generates maximum revenue from the Performance Enzymes segment. Geographically, it derives a majority of revenue from the APAC.

200 PENOBSCOT DRIVE
REDWOOD CITY, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

04/22/2010

Market Cap

202,500,312

Shares Outstanding

69,830,000

Weighted SO

69,830,199

Total Employees

N/A

Upcoming Earnings

08/01/2024

Similar Tickers

NUVB --.--%

LYEL --.--%

IPSC --.--%

GBIO --.--%

STTK --.--%

FHTX --.--%

GLUE --.--%

KYMR --.--%

NRIX --.--%

Beta

2.1210

Last Div

0.0000

Range

1.45-4.91

Chg

0.0600

Avg Vol

419150

Mkt Cap

202500312

Exch

NASDAQ

Country

US

Phone

650 421 8100

DCF Diff

6.7554

DCF

-3.3654

Div Yield

0.0000

P/S

3.3257

EV Multiple

-6.6526

P/FV

3.2870

Div Yield %

0.0000

P/E

-2.6451

PEG

-0.2982

Payout

0.0000

Current Ratio

2.9928

Quick Ratio

2.9197

Cash Ratio

0.6258

DSO

74.2588

DIO

47.5448

Op Cycle

121.8036

DPO

78.4958

CCC

43.3078

Gross Margin

0.7186

Op Margin

-1.0878

Pretax Margin

-1.2530

Net Margin

-1.2541

Eff Tax Rate

-0.0008

ROA

-0.5785

ROE

-0.9580

ROCE

-0.6528

NI/EBT

1.0008

EBT/EBIT

1.1519

EBIT/Rev

-1.0878

Debt Ratio

0.2450

D/E

0.5264

LT Debt/Cap

0.3158

Total Debt/Cap

0.3449

Int Coverage

67.2426

CF/Debt

-1.4623

Equity Multi

2.1483

Rec Turnover

4.9152

Pay Turnover

4.6499

Inv Turnover

7.6770

FA Turnover

2.3839

Asset Turnover

0.4613

OCF/Share

-0.6720

FCF/Share

-0.6980

Cash/Share

1.0475

OCF/Sales

-0.7767

FCF/OCF

1.0385

CF Coverage

-1.4623

ST Coverage

-11.8864

CapEx Coverage

-25.9440

Div&CapEx Cov

-25.9440

P/BV

3.2870

P/B

3.2870

P/S

3.3257

P/E

-2.6451

P/FCF

-4.1226

P/OCF

-4.2705

P/CF

-4.2705

PEG

-0.2982

P/S

3.3257

EV Multiple

-6.6526

P/FV

3.2870

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Apr 09, 21:00 Codexis Announces Byron Dorgan to Retire from Board of Directors GlobeNewswire Inc. Dec 27, 08:30 Codexis Announces Purchase Agreement with Nestlé Health Science for CDX-7108 GlobeNewswire Inc. Dec 11, 07:05 Codexis KOL Event Highlights Significant Need for an Enzymatic Route of Synthesis in RNAi Therapeutics Manufacturing GlobeNewswire Inc. Oct 27, 15:35 Codexis to Present Update on ECO Synthesis™ Platform at TIDES Europe

Revenue Product Segmentation